Kevin Kunzmann

The IGF-1R inhibitor becomes the first therapy indicated for the rare eye condition.

New data shows the market-controlling e-cigarette product nearly doubled its rate of young adult users in just 1 year.

New analysis feeds the belief that testosterone and estradiol influence asthma disparity between men and women.

A meta-analysis shows an association between respiratory burden and greater dementia risk, but the causes are still unknown.

The physician and memoir author shares his personal and professional perspective on what's needed to fix a broken system of care.

The GLP-1 agonist now has indications for the reduction of MACE and the management of A1C in patients with type 2 diabetes.

The weekly physician-led series will kick off on Monday, January 27.

The pediatric oncologist-turned-author gives perspective on the current suicide epidemic in the US, and what he learned from his own struggles.

New findings show patients with HDHPs are more likely to skip inhaler therapy due to costs, and are therefore more frequently hospitalized.

The tweet chat returns for a special crossover collaboration with a popular health data organization.

A long-term comparison trial with smokers motivated to quit show the combination of alternative nicotine products could slightly and safely improve cessation.

A comparison of virtual training to in-person education showed the former was noninferior to the latter among patients with asthma or COPD.

A certified physician assistant breaks down how dermatology specialty demand has influenced the modern care team.

How the two critical specialties become better bridged at medical meetings?

What the current critical care team looks like, and how it could be bettered.

A new study shows infants whose mothers received aid in managing their sleep duration and self-regulation did not significantly improve in such rates.

How women who undergo menopause before age 40 may be at a greater risk of heart disease.

A predictive assessment shows southern states will be the most burdened with rising rates of obesity and severe obesity—some nearing 60% of adults.

The compact delivery system is designed to reduce space needs for hospitals providing emergent care to patients with hypoxic respiratory failure associated with pulmonary hypertension.

A re-prioritization of disease monitoring and screening could help physicians better understand how one of the greatest killers in the US could be combated.

An assessment of metoprolol in older patients with COPD had to be discontinued after treated patients reported a greater rate of hospitalization due to exacerbations.

The approval makes it the first indicated by the FDA for cardiovascular risk reduction among patients with elevated triglyceride levels, as an add-on to maximally tolerated statin therapy.

The new indication will allow the longtime ALS therapy to be used among the 85% of patients required to use PEG due to dysphagia.

The once-daily therapy has been previously approved for treatment of adults with difficult-to-treat rheumatoid arthritis or psoriatic arthritis.

The Senate voted 72-18 to support the successor to Scott Gottlieb, MD, following a November hearing which raised questions to his stance on proposed tobacco and e-cigarette policies.

A look back at how chronic disease management, physician shortage, and newer therapies shaped the modern care team.

How primary care fits into the scheme of patient management, and what new therapies may mean for atopic dermatitis.

Nearly one dozen therapies have reached the psoriasis market, and the new standard is at least 90% skin clearance—an achievement previously unmet.

The investigative monoclonal antibody may become the first therapy indicated for the rare autoimmune disease.

New findings from a randomized, hospital-based trial in Nigeria show similar phase 2 results reported in the US for arginine as an adjuvant for vaso-occlusive pain episodes.